The portal is undergoing a scheduled maintenance today from 11:00 am to 4:30 pm ET. There may be brief periods of unavailability or portal slowness during this maintenance.

Millie
your market intelligence analyst
Search Results
34 results
Your search is now limited to «Melanoma» expert search.
BioNewsFeeds 10/23/2020 08:00
Adding UV1, Ultimovacs’ experimental cancer vaccine, to Keytruda (pembrolizumab) is safe and shows initial signs of effectiveness in adults with previously untreated metastatic melanoma, according to top-line data from a Phase 1 clinical trial. “The safety profile observed to date in this first cohort [group of patients] of the [UV1-Keytruda] combination study is consistent with the promising […]. .

Personal Care

Household Products

Business Issues

Trends

Companies - Public

Companies - Venture Funded

Information Technologies

Regions

Job Titles